Fig. 1From: Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapyTreatment flow and sample recruitment for JFMC34-0601, a multicenter prospective neoadjuvant exemestane studyBack to article page